Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cellsJORDAN, C. T ; UPCHURCH, D ; LUGER, S. M ; PHILLIPS, G. L ; SZILVASSY, S. J ; GUZMAN, M. L ; HOWARD, D. S ; PETTIGREW, A. L ; MEYERROSE, T ; ROSSI, R ; GRIMES, B ; RIZZIERI, D. ALeukemia, 2000-10, Vol.14 (10), p.1777-1784 [Periódico revisado por pares]London: Nature PublishingTexto completo disponível |
|
2 |
Material Type: Artigo
|
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemiaGiles, F J ; Swords, R T ; Nagler, A ; Hochhaus, A ; Ottmann, O G ; Rizzieri, D A ; Talpaz, M ; Clark, J ; Watson, P ; Xiao, A ; Zhao, B ; Bergstrom, D ; Le Coutre, P D ; Freedman, S J ; Cortes, J ELeukemia, 2013-01, Vol.27 (1), p.113-117 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
3 |
Material Type: Artigo
|
Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTRWieduwilt, Matthew J ; Stock, Wendy ; Advani, Anjali ; Luger, Selina ; Larson, Richard A ; Tallman, Martin ; Appelbaum, Frederick ; Zhang, Mei-Jie ; Bo-Subait, Khalid ; Wang, Hai-Lin ; Bhatt, Vijaya Raj ; Dholaria, Bhagirathbhai ; Eapen, Mary ; Hamadani, Mehdi ; Jamy, Omer ; Prestidge, Tim ; Pulsipher, Michael ; Ritchie, David ; Rizzieri, David ; Sharma, Akshay ; Barba, Pere ; Sandmaier, Brenda M ; de Lima, Marcos ; Kebriaei, Partow ; Litzow, Mark ; Saber, Wael ; Weisdorf, DanielLeukemia, 2021-07, Vol.35 (7), p.2076-2085 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
4 |
Material Type: Artigo
|
Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemiaWEINBERG, J. B ; VOLKHEIMER, A. D ; RIZZIERI, D. A ; LEVESQUE, M. C ; DEKROON, R ; STRITTMATTER, W. J ; MIHOVILOVIC, M ; JIANG, N ; CHEN, Y ; BOND, K ; MOORE, J. O ; GOCKERMAN, J. P ; DIEHL, L. F ; DE CASTRO, C. MLeukemia, 2008-12, Vol.22 (12), p.2184-2192 [Periódico revisado por pares]Avenel, NJ: Nature Publishing GroupTexto completo disponível |
|
5 |
Material Type: Artigo
|
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AMLGarcia-Manero, Guillermo ; Podoltsev, Nikolai A ; Othus, Megan ; Pagel, John M ; Radich, Jerald P ; Fang, Min ; Rizzieri, David A ; Marcucci, Guido ; Strickland, Stephen A ; Litzow, Mark R ; Savoie, M Lynn ; Medeiros, Bruno C ; Sekeres, Mikkael A ; Lin, Tara L ; Uy, Geoffrey L ; Powell, Bayard L ; Kolitz, Jonathan E ; Larson, Richard A ; Stone, Richard M ; Claxton, David ; Essell, James ; Luger, Selina M ; Mohan, Sanjay R ; Moseley, Anna ; Appelbaum, Frederick R ; Erba, Harry PLeukemia, 2024-01, Vol.38 (1), p.58-66 [Periódico revisado por pares]EnglandTexto completo disponível |
|
6 |
Material Type: Artigo
|
Phase I and pharmacokinetic study of elacytarabine, a novel 5'-elaidic acid derivative of cytarabine, in adults with refractory hematological malignanciesGILES, F. J ; VEY, N ; RIZZIERI, D ; RAVANDI, F ; PREBET, T ; BORTHAKUR, G ; JACOBSEN, T. F ; HAGEN, S ; NILSSON, B ; O'BRIEN, SLeukemia, 2012-07, Vol.26 (7), p.1686-1689 [Periódico revisado por pares]Avenel, NJ: Nature Publishing GroupTexto completo disponível |
|
7 |
Material Type: Artigo
|
Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTRWieduwilt, Matthew J ; Stock, Wendy ; Advani, Anjali ; Luger, Selina ; Larson, Richard A ; Tallman, Martin ; Appelbaum, Frederick ; Zhang, Mei-Jie ; Bo-Subait, Khalid ; Wang, Hai-Lin ; Bhatt, Vijaya Raj ; Dholaria, Bhagirathbhai ; Eapen, Mary ; Hamadani, Mehdi ; Jamy, Omer ; Prestidge, Tim ; Pulsipher, Michael ; Ritchie, David ; Rizzieri, David ; Sharma, Akshay ; Barba, Pere ; Sandmaier, Brenda M ; de Lima, Marcos ; Kebriaei, Partow ; Litzow, Mark ; Saber, Wael ; Weisdorf, DanielLeukemia, 2021-07, Vol.35 (7), p.2140-2140 [Periódico revisado por pares]London: Nature Publishing GroupTexto completo disponível |
|
8 |
Material Type: Artigo
|
Phase i and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignanciesGiles, F J ; Vey, N ; Rizzieri, D ; Ravandi, F ; Prebet, T ; Borthakur, G ; Jacobsen, T F ; Hagen, S ; Nilsson, B ; O'Brien, SLeukemia, 2012-01 [Periódico revisado por pares]Springer NatureTexto completo disponível |
|
9 |
Material Type: Artigo
|
Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transferHOWARD, D. S ; RIZZIERRI, D. A ; GRIMES, B ; UPCHURCH, D ; PHILLIPS, G. L ; STEWART, A. K ; YANNELLI, J. R ; JORDAN, C. TLeukemia, 1999-10, Vol.13 (10), p.1608-1616 [Periódico revisado por pares]London: Nature PublishingTexto completo disponível |
|
10 |
Material Type: Artigo
|
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemiaKhalife, J ; Radomska, H S ; Santhanam, R ; Huang, X ; Neviani, P ; Saultz, J ; Wang, H ; Wu, Y-Z ; Alachkar, H ; Anghelina, M ; Dorrance, A ; Curfman, J ; Bloomfield, C D ; Medeiros, B C ; Perrotti, D ; Lee, L J ; Lee, R J ; Caligiuri, M A ; Pichiorri, F ; Croce, C M ; Garzon, R ; Guzman, M L ; Mendler, J H ; Marcucci, GLeukemia, 2015-10, Vol.29 (10), p.1981-1992 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |